United Asset Strategies Inc. Boosts Stock Position in The Clorox Company $CLX

United Asset Strategies Inc. increased its holdings in The Clorox Company (NYSE:CLX) by 4.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,356 shares of the company’s stock after purchasing an additional 1,367 shares during the quarter. United Asset Strategies Inc.’s holdings in Clorox were worth $5,059,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Kaufman Rossin Wealth LLC purchased a new stake in Clorox in the 1st quarter worth approximately $202,000. Humankind Investments LLC raised its holdings in shares of Clorox by 9.5% during the first quarter. Humankind Investments LLC now owns 2,198 shares of the company’s stock valued at $324,000 after acquiring an additional 190 shares in the last quarter. Credit Agricole S A lifted its stake in Clorox by 8.8% in the first quarter. Credit Agricole S A now owns 51,844 shares of the company’s stock worth $7,634,000 after acquiring an additional 4,202 shares during the period. Groupama Asset Managment boosted its holdings in Clorox by 1.6% in the first quarter. Groupama Asset Managment now owns 12,198 shares of the company’s stock valued at $1,784,000 after acquiring an additional 187 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S boosted its holdings in Clorox by 295.0% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 146,121 shares of the company’s stock valued at $21,516,000 after acquiring an additional 109,127 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.2%

NYSE:CLX opened at $121.0370 on Thursday. The firm has a market capitalization of $14.80 billion, a P/E ratio of 18.56, a PEG ratio of 0.97 and a beta of 0.49. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a one year low of $117.35 and a one year high of $171.37. The company’s 50-day simple moving average is $124.45 and its 200 day simple moving average is $135.84.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period last year, the business earned $1.82 earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.1%. This is a positive change from Clorox’s previous quarterly dividend of $1.22. The ex-dividend date of this dividend is Wednesday, August 13th. Clorox’s dividend payout ratio is presently 76.07%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CLX shares. UBS Group dropped their target price on shares of Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research report on Thursday, July 17th. Barclays reduced their price target on shares of Clorox from $129.00 to $119.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 15th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $144.00 to $140.00 and set a “neutral” rating for the company in a report on Friday, July 25th. Wells Fargo & Company lifted their price objective on Clorox from $135.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, August 1st. Finally, Jefferies Financial Group decreased their target price on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. One analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Reduce” and an average price target of $143.36.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.